TORONTO--(BUSINESS WIRE)--Synaptive Medical, a leader in automation and robotics, announced today it will highlight its products EvryTM, Modus PlanTM and ImageDriveTM at the Radiological Society of North America’s (RSNA) 2019 Scientific Assembly and Annual Meeting, which will convene at McCormick Place in Chicago, IL, from December 1-6.
“Our imaging products were designed to optimize workflows, improve safety and yield better patient outcomes at different crucial parts of the healthcare decision-making process whether it be at initial point-of-care, pre- or post-operative status or throughout surgical procedures,” said Cameron Piron, co-founder and chief strategy officer, Synaptive Medical. “The key advancements in the medical imaging field are integrated approaches and our technologies were designed to provide just this.”
Piron continued, “All of our products work in tandem to provide safer and more efficient workflows, whether it be timely diagnoses with EvryTM, our point-of-care, head-only, magnetic resonance imaging (MRI) system currently in development; smart medical imaging organizations for large scale research with ImageDriveTM; or Modus PlanTM, our software tool for automatically generated whole brain tractography, which offers surgeons a safer way to approach procedures like tumor resections.”
Synaptive will exhibit these products at RSNA for the first time at the North Hall - Booth #6509 from Sunday, December 1 to Thursday, December 5. For more information on the meeting and Synaptive’s presence, visit the RSNA Program.
About Synaptive Medical
Synaptive Medical Inc., a Toronto-based medical device and technology company, designs hardware and software technologies that cross traditional barriers in hospitals and improve patient care in and beyond the operating room. Synaptive’s Modus VTM and integrated BrightMatterTM solutions—including surgical planning, navigation and visualization, and an informatics platform—give leading clinicians and healthcare systems the information they need to ensure the best possible outcomes for patients.